00930nas a2200361   4500000000100000008004100001260001600042653001500058653001000073653000900083653001000092653002100102653002800123653002500151653002600176653002100202653003000223653001100253653001100264653001400275653001100289653002300300653001200323653002000335653000900355653001600364653003000380245005200410856007400462300001100536490000700547022001400554       1995                            d  c1995 Sep 2210aAdolescent10aAdult10aAged10aChild10aChild, Preschool10aCross-Sectional Studies10aDeveloping countries10aDisability Evaluation10aDisabled Persons10aDrug Therapy, Combination10aFemale10aHumans10aIncidence10aInfant10aLeprostatic Agents10aleprosy10aLife Expectancy10aMale10aMiddle Aged10aWorld Health Organization00aLeprosy disabilities: magnitude of the problem.  uhttp://apps.who.int/iris/bitstream/10665/229537/1/WER7038_269-275.PDF  a269-750 v70  a0049-8114